Aurobindo Pharma Ltd
₹1237.40
(5.67)%
Tue, 03 Feb 2026, 09:10 am
Health Technology
Pharmaceuticals: Other
24.5K1 Day
0 (0%)
No Result Found
Summary
Market Cap
68250
Net Profit
3483.57
P/B
2.06
Sector P/E
31.51
P/E
19.32
EV/EBITDA
9.39
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
16.31
ROCE (Industry)
15.98
RONW (Industry)
14.01
ROE
11.15
ROCE
14.16
Debt/Equity
0.24
EPS (TTM)
58.93
Dividend Yield
0
Book Value
603.32
Interest Cover
12.08
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are thoroughly covered by earnings (11.4x coverage).
- Dividends after 3 years are expected to be thoroughly covered by earnings (12x coverage).
- Aurobindo Pharma's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Aurobindo Pharma's earnings are expected to exceed the low risk growth rate next year.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Aurobindo Pharma's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Aurobindo Pharma's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Cash flow for Aurobindo Pharma is expected to decrease over the next 2 years.
- Aurobindo Pharma's earnings are expected to grow by 9.7% yearly, however this is not considered high growth (20% yearly).
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 51.82 | 51.82 | 51.82 | 51.82 | 51.82 |
| FII | 13.94 | 14.21 | 14.37 | 15.33 | 16.29 |
| DII | 27.68 | 27.60 | 26.93 | 26.23 | 25.20 |
| Public | 6.55 | 6.38 | 6.87 | 6.61 | 6.69 |
| Government | 0 | 0 | 0.00 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1507.43 | 1352.83 | 1280.27 | 1198.23 | 1125.67 | 1043.63 | 889.03 |
| Fibonacci | 1352.83 | 1293.78 | 1257.29 | 1198.23 | 1139.18 | 1102.69 | 1043.63 |
| Camarilla | 1250.21 | 1236.04 | 1221.87 | 1198.23 | 1193.53 | 1179.36 | 1165.19 |
Pivots Level: Classic
R3
+309.20
1507.43
R2
+154.60
1352.83
R1
+82.03
1280.27
S1
-72.57
1125.67
S2
-154.60
1043.63
S3
-309.20
889.03
Moving Average
Period
Value
10-EMA
1177.62
20-EMA
1176.02
30-EMA
1178.23
50-EMA
1177.20
100-EMA
1165.92
200-EMA
1162.73
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 05 Nov 2025 | board-meetings | Quarterly Results | |
| 12 Aug 2025 | agm | ||
| 04 Aug 2025 | dividend | ₹4.00 Dividend /Share | 08 Aug 2025 |
| 30 Jul 2024 | agm | ||
| 18 Jul 2024 | buyback | ||
| 10 Feb 2024 | dividend | ₹1.50 Dividend /Share | 20 Feb 2024 |
| 09 Nov 2023 | dividend | ₹3.00 Dividend /Share | 20 Nov 2023 |
| 28 Jul 2023 | agm | ||
| 09 Feb 2023 | dividend | ₹3.00 Dividend /Share | 17 Feb 2023 |
| 07 Jul 2022 | agm |
Peer Comparison
Aurobindo Pharma Ltd
Divis Laboratories Ltd
Cipla Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
About Aurobindo Pharma Ltd
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1986
Headquarters
CEO
M R Kumar
Employees
Contact
Website
http://www.aurobindo.com
cs@aurobindo.com; investorgrievances@aurobindo.com
Phone
91-40-23736370
Location
Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet, Hyderabad, Telangana, 500038
aurobindo pharma ltd History
| Year | History |
|---|---|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800